AKT3 activation mediates resistance to HER2-targeted therapies in HER2-amplified breast cancer Meeting Abstract


Authors: Carmona Sanz, F.; Montemurro, F.; Rossi, V.; Verma, C.; Berger, M.; Baselga, J.; Scaltriti, M.
Abstract Title: AKT3 activation mediates resistance to HER2-targeted therapies in HER2-amplified breast cancer
Meeting Title: 26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Journal Title: European Journal of Cancer
Volume: 50
Issue: Suppl. 6
Meeting Dates: 2014 Nov 18-21
Meeting Location: Barcelona, Spain
ISSN: 0959-8049
Publisher: Elsevier Inc.  
Date Published: 2014-11-01
Start Page: 27
End Page: 28
Language: English
ACCESSION: WOS:000347755700070
PROVIDER: wos
DOI: 10.1016/S0959-8049(14)70195-9
Notes: Meeting Abstract: 69 -- 26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics -- NOV 18-21, 2014 -- Barcelona, SPAIN -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Michael Forman Berger
    765 Berger
  2. Jose T Baselga
    484 Baselga
  3. Maurizio Scaltriti
    169 Scaltriti